Quantitative structure-activity relationship studies on cholecystokinin antagonists

被引:9
作者
Gupta, SP [1 ]
机构
[1] Birla Inst Technol & Sci, Dept Chem, Pilani 333031, Rajasthan, India
关键词
D O I
10.2174/1381612023396500
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A review is presented on quantitative structure-activity relationship (QSAR) studies on cholecystokinin antagonists. Cholecystokinin (CCK) is a gastrointestinal peptide hormone closely related chemically to gastrin. However, its receptors are found in both peripheral and central nervous systems. Those present in peripheral system have been termed as CCK-A receptors and those present in central nervous system as CCK-B receptors. QSAR studies verify that CCK-B receptors are closely related structurally to gastrin receptors. QSAR studies have been reported on different classes of CCK antagonists, e.g., benzodiazepine derivatives, amino acid derivatives, quinazolinones, and peptides and pseudopeptide analogs. These QSAR studies unravel the mechanisms of interactions of each category of antagonists with the CCK receptors. In the case of benzodiazepines, the hydrophobic interactions and hydrogen bondings are found to be the most important binding force, while in the case of quinazolinones, only the hydrogen bonding is found to be important. The hydrophobic as well as the dispersion interactions are shown to be important for the binding of glutamic acid analogs and steric factors appear to govern the activity of peptides and pseudopeptide analogs.
引用
收藏
页码:111 / 124
页数:14
相关论文
共 85 条
  • [1] DIAZEPAM-BINDING INHIBITOR - A NEUROPEPTIDE LOCATED IN SELECTED NEURONAL POPULATIONS OF RAT-BRAIN
    ALHO, H
    COSTA, E
    FERRERO, P
    FUJIMOTO, M
    COSENZAMURPHY, D
    GUIDOTTI, A
    [J]. SCIENCE, 1985, 229 (4709) : 179 - 182
  • [2] ANATASI A, 1967, EXPERIENTIA, V23, P699
  • [3] Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988
    AugelliSzafran, CE
    Horwell, DC
    Kneen, C
    Ortwine, DF
    Pritchard, MC
    Purchase, TS
    Roth, BD
    Trivedi, BK
    Hill, D
    SumanChauhan, N
    Webdale, L
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (10) : 1733 - 1745
  • [4] CYCLIC-NUCLEOTIDE ANTAGONISTS OF CHOLECYSTOKININ - STRUCTURAL REQUIREMENTS FOR INTERACTION WITH THE CHOLECYSTOKININ RECEPTOR
    BARLAS, N
    JENSEN, RT
    BEINFELD, MC
    GARDNER, JD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 242 (02): : G161 - G167
  • [5] CHOLECYSTOKININ IN THE CENTRAL NERVOUS-SYSTEM - A MINIREVIEW
    BEINFELD, MC
    [J]. NEUROPEPTIDES, 1983, 3 (06) : 411 - 427
  • [6] BOC MG, 1989, J MED CHEM, V32, P13
  • [7] BOREA PA, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1086
  • [9] A POTENT NONPEPTIDE CHOLECYSTOKININ ANTAGONIST SELECTIVE FOR PERIPHERAL-TISSUES ISOLATED FROM ASPERGILLUS-ALLIACEUS
    CHANG, RSL
    LOTTI, VJ
    MONAGHAN, RL
    BIRNBAUM, J
    STAPLEY, EO
    GOETZ, MA
    ALBERSSCHONBERG, G
    PATCHETT, AA
    LIESCH, JM
    HENSENS, OD
    SPRINGER, JP
    [J]. SCIENCE, 1985, 230 (4722) : 177 - 179
  • [10] CORRELATION-ANALYSIS AND MOLECULAR MODELING OF CHOLECYSTOKININ INHIBITORS
    COATS, EA
    KNITTEL, JJ
    [J]. QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1990, 9 (02): : 94 - 101